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Tuning the Antimicrobial Activity of Low Molecular Weight 
Hydrogels Using Dopamine Autoxidation
Emily R. Cross,a Sophie M. Coulter,b Ana M. Fuentes-Caparrós, a Kate McAulay, a Ralf Schweins,c 
Garry Laverty,b,* and Dave J. Adamsa,*
We present a method to trigger the formation of dipeptide-based 
hydrogels by the simple addition of dopamine. Dopamine 
undergoes oxidation in air, reducing the pH to induce gelation. The 
production of polydopamine and release of reactive oxygen species 
such as hydrogen peroxide confers antimicrobial activity. Gel 
stiffness can be controlled by modulating the initial starting pH of 
the gelator solution. We can use this method to tune the 
antimicrobial activity of the gels, with gels that are less stiff 
demonstrating increased bactericidal efficacy against Gram-
positive bacteria. 
The use of medical implants such as intravascular and urinary 
catheters, heart valve prostheses, artificial hip joints, dental 
implants and intraocular lenses have increased in recent years 
due to both an ageing population and an improvement in 
medical healthcare.1, 2 Following the increase in medical implant 
usage, rates of infection due to bacterial adherence followed by 
biofilm formation on the implant surface has also increased.2-4 
Gels with antimicrobial properties can be used to coat medical 
implants to reduce the formation of microbial biofilms which 
lead to infectious disease.5-7
 The biocompatible nature of low molecular weight gelators 
(LMWG) makes them useful building blocks for antimicrobial 
gels.8 Antimicrobial gels can either be formed by encapsulation 
of a known antimicrobial agent into the gel or by developing the 
hydrogel network to possess antimicrobial activity. 
Encapsulation of silver and gold nanoparticles can lead to 
antimicrobial activity.3, 9-11 However, the mechanism which 
leads to these antimicrobial properties is unclear.8 It is possible 
that bacterial membrane damage is caused by the generation of 
reactive oxygen species binding to bacterial cell membranes.8 
Furthermore, antibiotics such as amoxicillin,12 vancomycin,13 
and gentamicin,14 can be also encapsulated into the gel 
network. Controlled release of these antibiotics into the area 
surrounding the biomaterial causes bacteria death.12, 14, 15 
However, antimicrobial gels formed by the physical 
encapsulation of antimicrobial agents can be problematic.16 
Accumulation of nanoparticles can be toxic and can cause 
various health problems and such formulations are prone to a 
high proportion of burst release.16-18 In order to prevent 
antimicrobial resistance development in the use of antibiotic 
encapsulated gels, it is critical that a sufficient concentration of 
antibiotic is released, that is above clinically effective 
concentrations for a sufficient period of time.19 At least 1% of 
bacteria in the stationary phase of biofilm development are 
tolerant to antibiotics; over time, the number of resistant 
microorganisms within the stationary phase can increase due to 
exposure to sub-therapeutic concentrations of antibiotics and 
therefore greater resistance can develop.20
Recently, there has been growing interest in the use of 
dopamine for surface modification to prevent microbial fouling. 
21 The production of polydopamine has been reported to display 
antimicrobial activity owing to the auto-oxidation of catechol in 
the presence of molecular oxygen to form semiquinone and 
quinone. During this oxidation process reactive oxygen species 
such as superoxide anions and hydrogen peroxide (H2O2) are 
generated as by-products.22 Despite widespread interest in the 
use of polydopamine as an antimicrobial agent, there is still 
dispute as to the exact mechanism by which it develops, 
however, it is known that the self-polymerization process 
requires alkaline conditions and the presence of oxygen.23 H2O2  
is well known for its antimicrobial activity, 3, 24 and the sustained 
release of H2O2 generated as a result of the dopamine self-
polymerization process has demonstrated broad spectrum 
antimicrobial activity against Gram-positive and Gram-negative 
organisms.22
One group of gels that has been used to form antimicrobial 
gels are LMWGs. Specifically here, we work with LMWG with a 
hydrophobic group attached to a dipeptide; this class can be 
tailored to specific requirements.25 Hydrogels are formed when 
these gelators self-assemble into one-dimensional aggregates, 
most commonly fibres, which entangle and immobilise water.26 
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The properties of the gels are determined by the nature of the 
fibres as well as the cross-links and microstructure.
The self-assembly of the gelators to form LMWG is controlled 
by a decrease in the solubility of the gelator in solution. There 
are many different methods to reduce the solubility of the 
gelators.26, 27 Here, we use a gelator where the solubility is 
controlled by pH. At high pH, the gelator disperses in water. 
When the pH is lowered, gelation occurs. Conventionally, this 
would be carried out using a mineral acid or via in situ hydrolysis 
of a lactone. Here, we show that the auto-oxidation of 
dopamine can be used to trigger a reduction in the pH and 
hence the solubility of gelator 1 in solution (Figure 1). We also 
show how we can control the antimicrobial properties of a gel 
by controlling the rate of gelation and gel stiffness. 
Figure 1. Chemical structures of (a) gelator 1 and (b) dopamine. (c) Oxidation 
pathway of dopamine, initial oxidation step produces protons which are used here 
to lower the pH of the bulk gelator solution, triggering gelation. A Michael addition 
and further oxidation forms the brown pigment leukoaminochrome and 
aminochrome.
Dopamine oxidises in air to produce dopaminoquinone and 
protons (Figure 1c).28, 29 The quinone undergoes intramolecular 
Michael addition forming aminochrome.29 This aminochrome 
can further polymerise into neuromelanin which is dark brown 
in colour. Several studies on the kinetic behaviour of dopamine 
autoxidation have been carried out.30-32 The summary of these 
kinetic studies suggest that the autoxidation of dopamine is 
strongly pH-dependent with the rate of autoxidation faster at 
higher pH.32 The increase in rate is due to the abundance of 
hydroxide ions which are required in the intramolecular Michael 
addition step. Babbit, Lloyd and more recently Salomäki et al. 
report the rate constant for the formation of aminochrome is 
first order.30, 31, 33 At low pH, the Michael addition is the rate 
limiting step.30 If we are able to control the rate of dopamine 
oxidation, we should be able to control the gelation kinetics of 
self-assembly.
Solutions of 1 were prepared at different initial pH values of 
7, 8, 9 and 10 at a concentration of 8 mg/mL. The apparent pKa 
of 1 is 6.8 and hence 1 is expected to be deprotonated in all 
these solutions (we refer to an apparent pKa since this is the pKa 
of the aggregate, see discussion in Figure S3). All solutions were 
viscous, as expected as 1 assembles into worm-like micelles at 
these pH values.34 In all cases, no gelation occurs with time for 
these solutions. However, a gel was formed when dopamine (3 
mg per mL) was added to a solution of gelator 1 (16 mg in 2 mL) 
at pH 8. To determine whether the effect of gelation was due to 
the oxidation products of dopamine or the electrostatic 
interactions between dopamine and the gelator in solution, two 
gels were prepared, one under a nitrogen atmosphere and the 
other under air. After 16 hours, the solution of 1 and dopamine 
which was under nitrogen did not form a gel whereas a gel was 
formed from the mixture in air. Furthermore, a brown colour 
gradient could be observed with a dark brown colour at the gel 
and air interface which faded into the bulk solution as shown in 
Figure 2. This led us to conclude that the oxidation of dopamine 
in air triggers gelation.
Figure 2. Image of gelator solutions of 1 (8 mg/mL, 2 mL sample) with dopamine 
(6 mg) under an atmosphere of (a) N2 and (b) air. The left-hand sample in both (a) 
and (b) show the solution before gelation and the right-hand sample shows the 
solution after 16 hours. Oxidation products of dopamine cause brown colour when 
the solution is left in air, which is absent under N2.  
To investigate the effect of pH on the rate of dopamine 
oxidation and gelation, dopamine (3 mg/mL) was added to stock 
solutions of 1 (8 mg/mL) at a pH of 7, 8, 9 or 10 (for full 
experimental see Supporting Information). After 16 hours, in all 
cases, the sample could be inverted without flow. Again, the 
dark brown colour gradient starting from the gel/air interface 
was observed. For the samples at the higher initial pH, the 
brown colour extended further into the bulk solution; for the 
sample starting at pH 7 the brown colour was only observed 
near the gel-air interface. We assume that this brown colour 
corresponds to the presence of dopamine oxidation products 
and polydopamine which are highly coloured.35 In all cases, 
after 16 hours, the pH of the solution was between 7.0 and 7.3.
Rheological analysis was carried out to further investigate 
the effect of the initial pH of the gelator solution pH on the final 
gel properties. Frequency and strain sweeps were used to 
determine the stiffness and breaking points of the gels (Figure 
3a). All gels show frequency independence at the measured 0.1-
100 rad/s angular frequency. Remarkably, a linear relationship 
between the gel stiffness and the pH of the starting solution was 
observed (Figure 3b). We describe this linear relationship as an 
effect of the first order rate kinetics of dopamine oxidation.30 As 
the pH decreases, the rate of dopamine oxidation is slower. The 
resulting gels are stiffer as the oxidation rate is slower (Figure 
3b). This phenomenon of gel stiffness being controlled with the 
rate of gelation has been previously seen in other low molecular 
weight hydrogels.36 There are small changes to the rheology and 
pH of the gels over time (Figure S3).
Drying such gels can lead to morphological changes;37 as 
such, we use small angle neutron scattering (SANS) to access 
information as to the morphology of the structures that are 
underpinning the gel network. This can be used directly on 
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hydrated gels. For the gels formed from initial pH values of 7, 8, 
and 9, the data can be fitted to a core-shell model combined 
with a power law to take into account the scattering at low Q. 
The full scattering data and fits are shown in the Supporting 
Information. The fits imply that the core is larger for the gels 
formed from the initial pH 7 solutions, whilst those formed from 
the solutions at pH 8 and 9 are very similar. There is a hydrated 
shell around the fibres, which increases in size at lower initial 
pH. The scattering length density (SLD) is higher than would be 
expected from the structure of polydopamine; we suspect that 
this implies that the coating is highly hydrated. This suggests 
that the slow oxidation at the initially lower pH results in a 
polydopamine ‘shell’ forming around the fibres. The data for the 
sample that was initially pH 10 fits best to a cylinder combined 
with a power law. implying that at the initially high pH, the fast 
rate means no coating forms. Hence, it is likely that the gel 
stiffness is affected by the presence of a polydopamine coating 
in some cases, which may result in cross-links between fibres. 
Figure 3. (a) Frequency sweep showing the storage and loss moduli of gels formed 
from 1 on adding dopamine to at an initial pH of 7 (black), 8 (blue), 9 (red) and 10 
(green), storage moduli have closed circles, loss moduli have open circles. (b) 
Storage moduli at a frequency of 10 rad/s versus pH. The linear regression (r2) is 
0.98988. 
Bacterial susceptibility assays were performed to assess 
antimicrobial activity of the gels and to examine whether there 
was any correlation between final gel stiffness, initial pH, 
polydopamine/H2O2 production and antimicrobial activity. In 
order to do this, bacterial susceptibility assays were performed 
against clinically relevant Gram-positive and Gram-negative 
organisms with the ability to reduce bacterial viability measured 
using a colony counting method providing bacterial numbers as 
Log10 colony forming units per mL (Log10 CFU/mL). A 
(hydroxypropyl)methyl cellulose (HPMC) control was employed 
as an inert hydrogel to study the effect of the presence of a 
gelator on bacterial viability.38, 39 All data were collected on gels 
formed after 24 hours, removing any potential ageing issues.
We observed antimicrobial activity against the Gram-
positive bacteria Staphylococcus aureus when pH 10 was used 
to initiate gelation and Staphylococcus epidermidis when both 
pH 9 and 10 were used to initiate gelation (Figure 4). We 
highlight again that all gels once formed were at a pH of between 7.0 
and 7.3. In each case, at least a three log reduction in bacterial counts 
was observed and this was used to denote clinical significance.40 
Remarkably, the antimicrobial properties increased as the gel 
stiffness decreased. This contrasts with other studies relating to 
the antimicrobial activity of peptide gelators. For example, work 
by Jiang et al. demonstrated a correlation between an increase 
in storage modulus and more effective bacterial inhibition and 
suggested that increased storage modulus provides the 
required mechanical support for individual nanofibres and 
fibrous networks to direct their desirable chemical and 
biological functionalities against bacteria.38 This leads us to 
believe that the differences observed in antimicrobial activity 
seen here are likely due to the production of polydopamine and 
reactive oxygen species rather than the gelator itself. If the 
gelator alone were responsible for the antimicrobial activity, 
then it would be expected that an increase in stiffness should 
result in an increase in antimicrobial activity in line with other 
studies. 
We suggest that with increasing pH used for initiating 
gelation, there is an increase in the rate of polydopamine 
production and therefore a subsequent increase in H2O2 
release. Ball et al. investigated the kinetics of the formation of 
polydopamine films under various pH conditions and found that 
the thickness of the film formed increased from pH 5.5 to pH 8 
indicating that more polydopamine was produced under 
increasing alkaline conditions.41 The decrease in gel stiffness 
and fibre entanglement observed for gels produced under a 
higher pH may promote diffusion of H2O2 through the network 
pores to enable increased interaction with bacterial cell 
membranes and intracellular targets (e.g. DNA) thereby 
enabling a bactericidal effect.42 The lack of activity observed for 
Gram-negative organisms (Figure S5) may be due to differences 
in the membrane architecture or detoxification of reactive 
oxygen species. The additional outer lipopolysaccharide 
membrane in Gram-negative organisms is well documented for 
its ability to limit the influx and uptake of antibiotic molecules, 
including reactive oxygen species.43 Bacteria also demonstrate 
an ability to reduce the damaging effects of reactive oxygen 
species through the production of neutralising molecules such 
as the exopolysaccharide Psl in biofilm forming isolates of P. 
aeruginosa.44 Interestingly, work by Forooshani et al. found the 
sustained release of low doses of H2O2, generated during 
polydopamine production, was sufficient to achieve broad 
spectrum activity against both Gram-positive and Gram-
negative bacteria.22 Antibacterial efficacy may therefore be a 
concentration dependent effect reliant on the rate at which 
H2O2 or other reactive oxygen species are produced within the 
system. Gram-negative microorganisms demonstrate increased 
resistance to reactive oxygen species, requiring increased 
exposure time or concentration to achieve significant kill.22 
Unfortunately, it is not possible to determine due to the colour 
of our gels as well as the assays only being suitable for fully 
solubilised systems. 
In conclusion, we present a new gelation trigger method for 
low molecular weight hydrogels. Using this method the gel 
stiffness can be controlled by the initial starting pH of the 
gelator solution. SANS data show how the composition of the 
gel fibres are similar at low Q therefore, the differences in gel 
stiffness are due to the entanglement of the fibres. We 
demonstrate that less stiff gels show greater antimicrobial 
properties towards Gram-positive bacteria and attribute this to 
the production of ROS as a result of the auto-oxidation of 
dopamine to produce polydopamine. This suggests potential to 
control the antimicrobial properties of a gel by controlling the 
mechanical properties of gelation.
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Figure 4. Bacterial susceptibility assays for (a) Staphylococcus aureus NCTC 10788 
and (b) Staphylococcus epidermidis ATCC 12228. Results displayed as bacterial 
counts in Log10 colony forming units per mL (Log10 CFU/mL). In both parts, gels of 
1 formed at different initial pH values with dopamine are shown as grey bars, 
negative PBS control as black triangles, HPMC controls as black square.
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